Literature DB >> 21042800

Symptomatic noncompressive motoromyelopathy presents as early manifestation in ankylosing spondylitis.

Wei-Hsi Chen1, Hsin-Ling Yin, Hung-Sheng Lin, Chung-Jen Chen.   

Abstract

Ankylosing spondylitis (AS) is an autoimmune spondyloarthropathy involving principally the sacroiliac joint and axial skeleton. Spinal cord involvement is an infrequent and late complication. It mostly results from compressive myelopathy due to skeletal osteopathy and usually presents with radiculomyelopathic sensory and motor deficits. To report three patients who suffered a progressive paraparesis/tetraparesis compatible with motor myelopathy without typical skeletal symptom. Myelopathy of unknown origin was initially interpreted in these patients. Radiography did not show typical change at sacroiliac joint or vertebrate. Spinal magnetic resonance image revealed cord atrophy at cervical and thoracic segment. A positivity of B27 antigen was found afterward. Their spondyloarthropathic symptoms developed within six months later with radiographic sacroiliitis. Seropositive AS with noncompressive myelopathy was finally established. Patients showed a reverse of motor impairment when their pain was well undercontrolled. Motor myelopathy may be neglected or underestimated in AS, in especially when typical skeletal symptom is absent or minimal. It may progress surreptitiously to harm spinal function or superimpose to crippling disability in compressive spinal cord injury. Therefore, a careful evaluation and monitor of spinal cord function is important for AS patient despite spinal deformity is not observed.

Entities:  

Mesh:

Year:  2010        PMID: 21042800     DOI: 10.1007/s00296-010-1614-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  33 in total

1.  Transverse myelitis in a patient with long-standing ankylosing spondylitis.

Authors:  D H Oh; J B Jun; H T Kim; S W Lee; S S Jung; I H Lee; S Y Kim
Journal:  Clin Exp Rheumatol       Date:  2001 Mar-Apr       Impact factor: 4.473

2.  Unusual occurrence of ankylosing spondylitis and multiple sclerosis in a black patient.

Authors:  G J Whitman; M A Khan
Journal:  Cleve Clin J Med       Date:  1989 Nov-Dec       Impact factor: 2.321

3.  Ankylosing spondylitis and multiple sclerosis: a possible association.

Authors:  M A Khan; I Kushner
Journal:  Arthritis Rheum       Date:  1979-07

Review 4.  Ankylosing spondylitis and spinal cord injury: origin, incidence, management, and avoidance.

Authors:  W Bradley Jacobs; Michael G Fehlings
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

Review 5.  HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.

Authors:  Denise U Goncalves; Fernando A Proietti; Edel F Barbosa-Stancioli; Marina L Martins; João G Ribas; Olindo A Martins-Filho; Andrea Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Anna B Carneiro-Proietti
Journal:  Inflamm Allergy Drug Targets       Date:  2008-06

Review 6.  Acute transverse myelitis: a practical reappraisal.

Authors:  Maria José Sá
Journal:  Autoimmun Rev       Date:  2009-04-21       Impact factor: 9.754

Review 7.  Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications.

Authors:  L A Westerveld; J J Verlaan; F C Oner
Journal:  Eur Spine J       Date:  2008-09-13       Impact factor: 3.134

8.  [A forty-five-years-old woman suffered from Sjögren syndrome with progressive tetraparesis].

Authors:  Fumitaka Shimizu; Motoharu Kawai; Michiaki Koga; Yasuteru Sano; Kiyoshi Negoro; Takashi Kanda
Journal:  Rinsho Shinkeigaku       Date:  2007-08

Review 9.  Ankylosing spondylitis.

Authors:  Jürgen Braun; Joachim Sieper
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

10.  Neurological complications of ankylosing spondylitis: neurophysiological assessment.

Authors:  Eman M Khedr; Sonia M Rashad; Sherifa A Hamed; Fatma El-Zharaa; Abdel Karim H Abdalla
Journal:  Rheumatol Int       Date:  2009-01-20       Impact factor: 2.631

View more
  1 in total

1.  Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis.

Authors:  Li Zhang; Hui Ouyang; Zhen Xie; Zhi-Hui Liang; Xiong-Wen Wu
Journal:  Exp Mol Med       Date:  2016-04-22       Impact factor: 8.718

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.